Publicacións (18) Publicacións de África González Fernández

filter_list Internal Medicine

2023

  1. Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice

    Frontiers in Immunology, Vol. 14

2022

  1. Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor

    Cancers, Vol. 14, Núm. 13

  2. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells

    Pharmaceuticals, Vol. 15, Núm. 7

2020

  1. An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis Profile

    Frontiers in Immunology, Vol. 11

  2. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection

    PLoS ONE, Vol. 15, Núm. 7 July

  3. Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection

    Journal of Infection, Vol. 81, Núm. 1, pp. 57-71

  4. Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts

    Journal of Proteomics, Vol. 195, pp. 41-52

2018

  1. Flagellin is a Th1 polarizing factor for human CD4+ T cells and induces protection in a murine neonatal vaccination model of rotavirus infection

    Vaccine, Vol. 36, Núm. 29, pp. 4188-4197

2015

  1. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

  2. Predominant role of interferon-γ 3 in the host protective effect of CD8 + T cells against Neospora caninum infection

    Scientific Reports, Vol. 5, pp. 1-14

2012

  1. Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis

    BMC Infectious Diseases, Vol. 12

2011

  1. Eje interleucina 12/interferón gamma en pacientes de tuberculosis en una región Europea con alta incidencia de enfermedad

    Inmunologia, Vol. 30, Núm. 2, pp. 36-44

  2. Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells

    Cellular Immunology, Vol. 271, Núm. 2, pp. 319-328

2010

  1. Minireview: Nanoparticles and the immune system

    Endocrinology

2009

  1. Tendencias seculares en la morbimortalidad y costes de hospitalización por tuberculosis en Galicia

    Galicia Clínica, Vol. 70, Núm. 1, pp. 19-24

2005

  1. Linfocitos T y B. Clasificación. Receptores. Generación de diversidad: mecanismos moleculares. Capacidades funcionales

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 33, pp. 2162-2173

2004

  1. A new potential therapeutic agent against B cell malignancies

    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION